We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Applied Sciences

Applied Sciences

Stay up to date on the topics that matter to you

Molly Coddington profile page

Senior Writer and Newsroom Team Lead

at Technology Networks

Molly reports on various scientific topics, covering the latest breaking news and writing long-form pieces. In 2020, she created the Teach Me in 10 video series, where weekly guests discuss and teach a scientific concept in less than 10 minutes. Before joining Technology Networks in 2019, Molly worked as a clinical research associate in the NHS and as a freelance science writer. She has a first-class honors degree in neuroscience from the University of Leeds and received a Partnership Award for her efforts in science communication.

Education

University of Leeds

Awards & Certifications

Georgina Henry Award for Digital Innovation Nominee

Lord Laidlaw Scholarship Recipient, University of Leeds

Partnership Award, University of Leeds

Accreditations

Neuroscience, BSc (Hons) recognised by the University of Leeds

Areas of Expertise

Got a Question for Molly Coddington?

Get in touch using the contact form linked here and we’ll get back to you shortly.

Published Content

Total: 910

Alzheimer’s Expert: What Does the Future of Dementia Diagnosis Look Like?

Technology Networks interviewed Professor Henrik Zetterberg on World Alzheimer’s Day 2024 to learn more about his work and his outlook on the future of AD and dementia research.

White and brown stones.

5D Memory Crystal Could Preserve Human DNA for Billions of Years

A team of researchers at the University of Southampton say they have etched the full human genome onto a 5D memory crystal, which can survive for billions of years.

A picture of Professor Giles Oldroyd.

Professor Giles Oldroyd: "It Takes Bravery To Be Openly Queer"

Professor Giles Oldroyd is one of the few openly queer scientists who have been inducted into both the prestigious Royal Society (UK) and the National Academy of Sciences (USA). In this interview, he speaks candidly about his experiences in STEMM.

An image of James Hallam, vice president of the Research, Development and Advanced Testing Business Segment at Waters Corporation.

Industry Insight

Next-Generation Solutions for Discovery Omics

Learn from James Hallam, vice president of the Research, Development and Advanced Testing Business segment at Waters Corporation, about how technological advancements in mass spectrometry are powering new discoveries in omics research.

A veteran with PTSD sits on a sofa.

Industry Insight

After MDMA’s FDA Approval Setback, Science Must Lead the Way

Dr. Sergio Pérez Rosal explains why, in his opinion, “hope is not lost” and the therapeutic potential of psychedelics for the treatment of psychiatric disorders could still be unlocked. But what happens next must be firmly rooted in science.

A bed floating on clouds with a lamp hanging over.

How Does the Sleeping Brain Support a Day’s Worth of Memories?

Dr. George Dragoi from Yale University discusses his latest work on memory consolidation during sleep with Technology Networks.

Close up of octopus tentacles.

How To Enter a New Chapter in Academic Publishing

In this interview, Alex Freeman, the founder of Octopus, discusses the progress made since the platform's launch and the ongoing challenges of establishing a new paradigm in academic publishing.

Lab bench with data falling down the page and titled data compliance within the laboratory

Data Compliance Within the Laboratory

Data powers scientific discovery and directs new areas of research. Download this infographic to learn more about the importance of data compliance, differing data compliance regulations and how the compliance process can be simplified.

A psychedelic-esque graphic.

Rapid Tagging Method Reveals Psychedelics' Immediate Effects on Neurons

Neuron-tagging method developed by researchers at UC Davis reveals how psychedelic compounds impact individual neurons in the brain.

Victoria Gray and her husband Earl stand together, surrounded by illustrations of blood cells and DNA.

Breaking the Chains: How CRISPR Gene Therapy Gave Victoria Gray a New Life

This article tells the story of Victoria Gray, the first patient to receive a CRISPR cell-based gene therapy for sickle cell disease (SCD). We explore the struggles of SCD, the mistreatment of minorities in medical settings and the implications of gene therapy accessibility.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter